Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Shares Cross Above Two Hundred Day Moving Average – What’s Next?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS)’s stock price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $22.85 and traded as high as $24.30. Fresenius Medical Care AG & Co. KGaA shares last traded at $24.0750, with a volume of 509,060 shares traded.

Wall Street Analysts Forecast Growth

FMS has been the topic of several research reports. Wall Street Zen lowered Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Weiss Ratings cut Fresenius Medical Care AG & Co. KGaA from a “hold (c+)” rating to a “hold (c)” rating in a research note on Thursday, May 7th. Jefferies Financial Group upgraded Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “moderate sell” rating in a report on Friday, May 8th. Morgan Stanley reiterated an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Wednesday, May 6th. Finally, Zacks Research upgraded shares of Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “hold” rating in a research note on Monday, July 6th. Six equities research analysts have rated the stock with a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat.com, Fresenius Medical Care AG & Co. KGaA has an average rating of “Reduce” and an average price target of $28.00.

Fresenius Medical Care AG & Co. KGaA Price Performance

The stock has a 50 day moving average of $22.83 and a two-hundred day moving average of $22.86. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.86 and a current ratio of 1.20. The firm has a market capitalization of $13.07 billion, a P/E ratio of 12.81, a P/E/G ratio of 4.34 and a beta of 0.78.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last announced its earnings results on Tuesday, March 31st. The company reported $1.05 earnings per share (EPS) for the quarter. Fresenius Medical Care AG & Co. KGaA had a return on equity of 8.90% and a net margin of 4.88%.The firm had revenue of $5.34 billion during the quarter. Sell-side analysts predict that Fresenius Medical Care AG & Co. KGaA will post 2.24 earnings per share for the current fiscal year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The company also recently announced an annual dividend, which was paid on Monday, June 8th. Investors of record on Friday, May 22nd were paid a $0.8716 dividend. This represents a yield of 402.0%. The ex-dividend date was Friday, May 22nd. This is a boost from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79. Fresenius Medical Care AG & Co. KGaA’s dividend payout ratio (DPR) is 32.11%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. CIBC Private Wealth Group LLC grew its position in shares of Fresenius Medical Care AG & Co. KGaA by 398.2% in the third quarter. CIBC Private Wealth Group LLC now owns 1,380 shares of the company’s stock valued at $36,000 after purchasing an additional 1,103 shares during the last quarter. Arax Advisory Partners lifted its position in shares of Fresenius Medical Care AG & Co. KGaA by 121.6% during the 4th quarter. Arax Advisory Partners now owns 1,613 shares of the company’s stock worth $38,000 after purchasing an additional 885 shares during the last quarter. Kestra Advisory Services LLC bought a new stake in Fresenius Medical Care AG & Co. KGaA during the 4th quarter valued at approximately $48,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in Fresenius Medical Care AG & Co. KGaA during the 4th quarter valued at approximately $58,000. Finally, Group One Trading LLC acquired a new stake in Fresenius Medical Care AG & Co. KGaA in the 3rd quarter valued at approximately $74,000. Institutional investors and hedge funds own 8.37% of the company’s stock.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.